Currency and US Demand Drive Biotage Sales First quarter sales for Biotage jumped 26.8%, 6.1% excluding currency, to SEK 144.2 million ($17.3 million = SEK 8.34 = $1). Sales were driven by double-digit growth for sample preparation products as the company introduced the Extrahera system. The new system is freely available to customers agreeing to […]
The latest IBO feature on new sources of R&D funding focuses on June announcements involving sales opportunities for companies producing instruments and lab products. The US government has revealed that more than $4 billion has been contributed by foundations, institutional investors, universities and other donors to the Clean Energy Investment Initiative. A group of long-term […]
Major US equity markets contracted roughly 2.0% or more on June 29 when Greece failed to reach an agreement with its international creditors. As a result, the country essentially defaulted on its $1.7 billion loan payment to the International Monetary Fund (IMF) the following day. While discussions are expected to continue, Greece no longer has […]
As the importance of the Chinese market has grown, so have foreign companies’ R&D efforts in the country. According to a survey of 477 US companies conducted by the American Chamber of Commerce in the People’s Republic of China (AmCham) and Bain & Company in February, 46% of the companies classified as R&D Intensive Industries […]
Productivity growth for instrument and laboratory product companies decelerated in fiscal year 2014 (FY14) due to the negative currency impact on revenue growth for most US companies, varied market demand and increased investments in personnel. With half of the companies recording productivity gains, the average sales-per-employee ratio for the 20 companies in the table on […]
IBO has selected Bruker’s MALDI Tissuetyper Solution with rapifleX MALDI-TOF MS as the product of the show for this year’s ASMS annual meeting. The system features performance improvements over other MALDI imaging instruments, in particular, its ability to provide acquisition of up to 50 pixels at fewer than 10 µm/sec, and a new 3-D laser […]
In May, the NSF’s National Center for Science and Engineering Statistics published an InfoBrief with its figures on federal funding for R&D for fiscal 2012–14 (FY12–14). The data were collected from February to August of 2014 from the “NSF Survey of Federal Funds for Research and Development: FYs 2013–15,” which was sent to federal agencies. […]
Expanding Markets Lift Affymetrix Q1 Sales Affymetrix first quarter sales grew 6.9%, 9% excluding currency, to $88.7 million. The negative impact from currency was partially reduced by hedging gains of $2.2 million. Product sales grew 7.7% to $79.4 million. Consumables sales grew 9.4%, and Instruments sales fell 23.5% to account for 86% and 3% of […]
The American Society of Mass Spectrometry (ASMS) held its 63rd annual conference from May 31 to June 4 at the downtown convention center in St. Louis, Missouri. Attendance totaled 6,101, falling 8.9% from last year (see IBO 6/30/14). MS companies at the conference focused on total-package solutions for research needs, unlike in previous years, when […]
Bad Timing for Agilent Agilent Technologies fiscal second quarter sales ending April 30 contracted 2.5% to $963 million due to stronger-than-expected currency headwinds and divested product lines. In addition, timing of orders and shipping delays from the new Americas logistics center negatively impacted revenue growth by $30 million, or 3.0% of revenue growth. In spite […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
